Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,883 | -5,533 | -6,172 | -2,029 | -3,533 |
| Other Working Capital | -213 | 1,936 | 2,209 | 55 | 1,161 |
| Other Operating Activity | 28,909 | 2,902 | 2,375 | 664 | 1,447 |
| Operating Cash Flow | $-2,187 | $-695 | $-1,589 | $-1,310 | $-925 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 418 | 760 | 605 | 725 | 564 |
| Common Stock Issued | 1,878 | N/A | 555 | 684 | N/A |
| Other Financing Activity | -15 | -51 | 212 | 129 | 243 |
| Financing Cash Flow | $2,281 | $709 | $1,372 | $1,537 | $807 |
| Beginning Cash Position | 49 | 34 | 250 | 24 | 141 |
| End Cash Position | 142 | 49 | 34 | 250 | 24 |
| Net Cash Flow | $93 | $15 | $-216 | $227 | $-118 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,187 | -695 | -1,589 | -1,310 | -925 |
| Free Cash Flow | -2,187 | -695 | -1,589 | -1,310 | -925 |